Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Enjoying now or saving for later: are we predisposed to choose?

Published on: 23/02/2023 Reading time: 1 min
Une horloge avec un fond de deux couleurs
Retour à la recherche

Léonie KOBAN and Hilke PLASMANN, researchers in the team "CIA: cognitive control - interoception - attention", have identified a novel brain marker using functional imaging that predicts our preference for immediate rewards over larger later rewards. This work is published in the Journal of Neuroscience.

Delay discounting (DD)

Delay discounting (DD) is a cognitive process that describes to what degree individuals are willing to wait for larger monetary pay-off that they receive in the future or whether they prefer to receive a smaller one now (e.g., 1 EUR now vs. 2 EUR in a week). The more people discount time, the more they to prefer to receive an immediate reward rather than wait for a larger reward that is only available in the future. We are all regularly faced with this type of choice: for instance, when we decide to buy some new shoes today or save to the money for a nice vacation in the summer, whether we eat a snack in the afternoon or save our appetite for dinner, and whether we go out with friends in the evening or go to bed early to be rested the next day.

DD is highly variable from one person to the next but remains stable over time for the same person. Previous studies have associated DD as a risk factor in eating disorders (obesity or anorexia), smoking, alcohol use disorder, or drug addiction.

The aim of the study conducted by the Institute's researchers was to identify a replicable machine-learning based brain marker predictive of DD and to validate it in an independent population.

 

Assessing trends in choices

To this end, 255 healthy volunteers were asked to make choices between smaller immediate and larger later rewards during a functional MRI scan. The researchers also measured the body weight and height, the percentage of fat mass, blood insulin, and glucose levels of the study participants.

 

Significant results: the brain signature of DD

The researchers from the ICM and their colleagues used a machine learning algorithm to detect a pattern of functional brain activity that could predict individual differences in delay discounting. Machine learning is a form of artificial intelligence that allows a mathematical and statistical model to predict new data based on previously analyzed data.

The results of the study showed that it was possible to predict a person’s degree of delay discounting based on their functional brain activity across different brain regions. Furthermore, the researchers found that the marker was related to individual differences in blood insulin and glucose—two metabolic markers—and that it  differed between overweight and normal weight individuals.

Future studies can test this marker in disorders characterized by impaired decision making, such as eating disorders, addictions, or neurodegenerative diseases like Alzheimer's or Parkinson's.

Sources

Koban L, Lee S, Schelski DS, Simon MC, Lerman C, Weber B, Kable JW, Plassmann H. An fMRI-based brain marker of individual differences in delay discounting. J Neurosci. 2023 Jan 18:JN-RM-1343-22. doi: 10.1523/JNEUROSCI.1343-22.2022. Epub ahead of print. PMID: 36657973.

Our news on the subject

Épilepsie temporale : une nouvelle stratégie pour corriger l’activité électrique anormale
Temporal Lobe Epilepsy: A New Strategy to Correct Abnormal Electrical Activity
Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...
03.06.2026 Research, science & health
Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
World Brain Health Forum 2026 Vignette
World Brain Health Forum 2026: making brain health a global priority
In January 2026, Paris Brain Institute organized the World Brain Health Forum, an international event that was at the heart of its 15th anniversary celebrations. Over three days, from January 14 to 16, around 80 international speakers and more than 1...
01.30.2026 Events
Lancement d’un programme mondial pour la santé cérébrale
Inaugural Global Brain Care Scholars Program
The Ban Ki-moon Foundation, the Paris Brain Institute, and the Vascular Brain Health Institute signed a new partnership agreement marking a major step to championing brain health, building local capacity, and specialized education to launch the...
01.29.2026 Institutional
See all our news